Description

NAD+ 500mg for Cellular Metabolism Research

Nicotinamide adenine dinucleotide (NAD+) is a naturally occurring coenzyme involved in cellular redox reactions and energy-transfer processes. It also participates in biological pathways involving enzymes such as sirtuins and poly(ADP-ribose) polymerases (PARPs).

Researchers study NAD metabolism in relation to cellular energy production, mitochondrial biology, oxidative stress, and age-associated biological changes. Much of the available human research has focused on NAD precursors, including nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), rather than establishing clinical benefits for a standalone NAD+ laboratory research product.

NexGen Peptides NAD+ 500mg is intended for controlled laboratory investigations involving:

• Cellular redox reactions
• Energy-transfer mechanisms
• Mitochondrial research models
• NAD-dependent enzyme activity
• Oxidative-stress pathways
• Metabolic signalling
• Compound stability and analytical testing

A recent retrospective commercial-clinic study examined intravenous NAD+ administration; however, its observational design does not establish broad safety, effectiveness, or anti-ageing benefits. Accordingly, this product must not be promoted as increasing energy, repairing DNA, extending lifespan, or providing therapeutic outcomes.

Product Information

Australian Regulatory Notice

The Therapeutic Goods Administration (TGA) states that NAD, NAD+, and NADH are not currently permitted ingredients in listed medicines. Products referring to these substances may breach Australian law when advertised or supplied as therapeutic goods without ARTG inclusion, an exemption, or another applicable authorisation.

Research-Use Notice

NAD+ 500mg is supplied exclusively for lawful laboratory research. It is not marketed as a vitamin, medicine, injection, anti-ageing treatment, or energy product. No administration, dosage, or self-use instructions should appear on the public product page.